Product Information
TERIPARATIDE 560 MCG/2.24 ML PEN is a generic product labeled by Amphastar Pharmaceuticals, Inc., priced at $494.8050 per ML under NDC 00548231100. Its NADAC has been published 26 times since Feb 25, 2026.
FDA first approved this application on Dec 12, 2025. Its Orange Book therapeutic-equivalence code is AP.
Strength
250 ug/mL
Manufacturer
Amphastar Pharmaceuticals, Inc.NDC
00548231100
Classification
Generic
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
TERIPARATIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213641FDA Approved
12/12/2025
TE Code
AP
On Market Since
12/22/2025
Pharmacological Classes
Price Statistics
The NADAC for TERIPARATIDE 560 MCG/2.24 ML PEN has been published 26 times since Feb 25, 2026, and over the history we have for it it has declined 20.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $494.8050 per ML |
|---|---|
| All-time high | $624.8910 (Mar 11, 2026) |
| All-time low | $494.8050 (Aug 19, 2026) |
| 52-week high | $624.8910 |
| 52-week low | $494.8050 |
| Median price | $536.5490 |
| Average price | $554.4408 |
| Largest weekly change | -9.3% (Apr 22, 2026) |
| Weeks tracked | 26 |
| Tracking since | Feb 25, 2026 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TERIPARATIDE 560 MCG/2.24 ML PEN?
The current National Average Drug Acquisition Cost (NADAC) for TERIPARATIDE 560 MCG/2.24 ML PEN, manufactured by Amphastar Pharmaceuticals, Inc., is $494.8050 per ML (NDC 00548231100), effective Aug 19, 2026.
How has the price of TERIPARATIDE 560 MCG/2.24 ML PEN changed over time?
Over the history we have for it, the NADAC for TERIPARATIDE 560 MCG/2.24 ML PEN has declined 20.8%. It has been tracked across 26 weekly CMS publications since Feb 25, 2026.
What are the highest and lowest recorded NADAC prices for TERIPARATIDE 560 MCG/2.24 ML PEN?
Since Feb 25, 2026, the NADAC for TERIPARATIDE 560 MCG/2.24 ML PEN has ranged from a low of $494.8050 (Aug 19, 2026) to a high of $624.8910 (Mar 11, 2026), with a median of $536.5490 per ML.
Are there cheaper alternatives to TERIPARATIDE 560 MCG/2.24 ML PEN?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TERIPARATIDE 560 MCG/2.24 ML PEN in a comparable dosage form, but none are currently priced below it.
Who manufactures TERIPARATIDE 560 MCG/2.24 ML PEN?
TERIPARATIDE 560 MCG/2.24 ML PEN (NDC 00548231100) is labeled by Amphastar Pharmaceuticals, Inc., and CMS classifies it as a generic product.